Tocqueville Asset Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-10,225
Closed -$233K 775
2018
Q4
$233K Sell
10,225
-8,000
-44% -$218K ﹤0.01% 673
2018
Q3
$580K Hold
18,225
0.01% 590
2018
Q2
$653K Buy
18,225
+8,100
+80% +$287K 0.01% 566
2018
Q1
$336K Buy
+10,125
New +$361K ﹤0.01% 685
2017
Q2
Sell
-35,000
Closed -$781K 805
2017
Q1
$781K Buy
+35,000
New +$725K 0.01% 524

Other funds holding EDIT

Tocqueville Asset Management's EDIT Position: Q1 2019 in Review

Tocqueville Asset Management sold out of Editas Medicine (EDIT) in Q1 2019, closing a stake of 10,225 shares — an estimated $233K sold.

Tocqueville Asset Management first reported a position in EDIT in Q1 2017 and held it in 5 quarters. The position peaked at $781K in Q1 2017. 201 funds tracked by Wall St. Rank hold EDIT as of Q1 2019.

  • Tocqueville Asset Management reported no remaining Editas Medicine position as of Q1 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 10,225 Editas Medicine shares in Q1 2019, an estimated $233K.
  • Tocqueville Asset Management first reported a position in Editas Medicine in Q1 2017 and held it in 5 quarters.
  • Tocqueville Asset Management's Editas Medicine position peaked at $781K in Q1 2017.
  • 201 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2019.

Based on Tocqueville Asset Management's 13F filing for Q1 2019, filed 30 Apr 2019.